Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
about
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialRecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisStroke rehabilitation: recent advances and future therapiesFatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke TrialRisk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.The synergistic effect of functional status and comorbidity burden on mortality: a 16-year survival analysis.Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysisCost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review.Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis.Predictors of long-term survival among first-ever ischemic and hemorrhagic stroke in a Brazilian stroke cohortCharacteristics of inpatient care and rehabilitation for acute first-ever stroke patients.Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).The prognostic factors that influence long-term survival in acute large cerebral infarctionCost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient ischemic attack and minor strokeBurden of ischemic stroke in Korea: analysis of disability-adjusted life years lost.Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.Korean Stroke Cohort for functioning and rehabilitation (KOSCO): study rationale and protocol of a multi-centre prospective cohort study.Disability-adjusted life years analysis: implications for stroke research.Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke.The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.Health technology assessment and its role in the future development of the Indian healthcare sector.Mediating effect of self-control in relation to depression, stress, and activities of daily living in community residents with stroke.Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 70 years old.Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke).A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.Association between acetylcholinesterase inhibitors and risk of stroke in patients with dementiaSeverity of leukoaraiosis correlates with clinical outcome after ischemic strokeLong-term survival after ischemic stroke in patients with atrial fibrillation.Causes of death among persons who survive an acute ischemic stroke.Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke.Added Value of Patient-Reported Outcome Measures in Stroke Clinical Practice.Independent predictors of mortality in subacute and chronic stroke patients: A single center study in Turkey.Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.Predictors of functional level and quality of life at 6 months after a first-ever stroke: the KOSCO study.Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation.Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.Activities of daily living dependency and disease-specific mortality during 12-year follow-up in an 80-year-old population.Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis.A case report exploring activity intensity in inpatient rehabilitation after stroke.
P2860
Q24595579-72494B26-BB58-462C-8443-F33E9126F5EDQ24595703-1CBC69B6-93B4-4683-B648-C2CD768E12FCQ26849846-9B92067F-48C0-469D-A788-1E79AE55C41DQ30000955-CBF53A3D-D816-4C1A-BA7B-EA30E611DE54Q33876319-3887CA5C-49AB-48DB-BAF6-155D8183E1F1Q34110560-B63EA578-89A7-4CE8-8579-A39A96E966F3Q34118097-8919A4A2-21EB-4A73-B67A-5B39580F45A1Q34180151-D7FB4F65-B7E2-4807-8807-BC414E37C58AQ34343826-6BBE205E-8762-4B93-A009-315B5E22FF9DQ34739413-A25E17AC-A94A-4617-ADCC-43D3D9E78B97Q34774183-88DA1CD4-395A-4B5B-B400-35A2A185BAAEQ34803882-8328241C-3CA1-45E9-854A-1B8763D45971Q34811144-B73CADE1-C541-40F2-9494-B0E1CF3CAA64Q35021898-B894EC38-1272-4C0C-BD91-3C11376B4D03Q35091676-3A4F50D9-75BE-44EC-BBA9-F05A0C207C79Q35118898-5F0BEC27-B2B0-4DD7-A41B-AC4D136E277EQ35222896-B13044D8-3E16-4722-AFCD-53865F076C1BQ35539636-BC69E348-2218-4899-B9F2-C3CE2913378FQ35943322-3857E1C8-6BB4-4680-BD70-15B528DCCE19Q35985956-BD043007-A46A-4841-A8A4-3C58D4D4957CQ36021214-418FF514-4DB9-4712-8CE5-B9436AC796BBQ36039375-9193D95A-138E-4A70-A4FC-0DBB7B84A58DQ36317317-BDEECE71-FBCE-4F62-8BEE-355FE57D431AQ36333639-FD09C2C7-BF37-4E0C-9324-5390BB45F355Q36685755-9E0D3BC8-B502-4A75-92D3-059869BB4B29Q37063986-983D91AD-077B-41BC-AE5C-73C8114A780FQ37180499-B11FBCE6-1AB0-4DC7-ADE0-AC29EB9DC2C4Q37657045-8F5BCBF4-3A1E-4676-93FE-71C0B7EF2AFCQ38222122-E6D8B60D-36A7-4D23-88B5-79BC3E6E41EBQ38225341-84F1BF86-5BD9-405B-948C-4C28E60BA700Q38614484-B2A9F344-5DAD-4240-981E-AAB983DFCEADQ38667236-630AF038-C0E1-46ED-8EF2-9CE282A5489CQ38683694-CA907E0A-7BC7-416E-9589-A88F785A7AA3Q39443618-943DE3A8-61CB-400C-A4DE-62EE4D6B899AQ39822632-2E7BC7DA-6936-4FCC-A001-850A40306A9EQ39953513-7205FEC6-3BB5-4022-99C4-115EC9DF2E5CQ40090622-D719070A-61C7-4C80-ADFD-579A4BED4543Q40115892-6F7CF9D4-9F7B-4BBD-8EBB-4DA26C3E188AQ41100489-2FCD0075-D321-477B-B977-914E4988A17CQ41931724-AACB9876-E39F-46EC-A772-9C818BEEB508
P2860
Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Impact of functional status at ...... ke: prospective cohort studies
@ast
Impact of functional status at ...... ke: prospective cohort studies
@en
type
label
Impact of functional status at ...... ke: prospective cohort studies
@ast
Impact of functional status at ...... ke: prospective cohort studies
@en
prefLabel
Impact of functional status at ...... ke: prospective cohort studies
@ast
Impact of functional status at ...... ke: prospective cohort studies
@en
P2093
P2860
P1433
P1476
Impact of functional status at ...... ke: prospective cohort studies
@en
P2093
Eivind Berge
Karsten Bruins Slot
Lothian Stroke Register
Martin Dennis
Oxfordshire Community Stroke Project, the International Stroke Trial (UK)
Paul Dorman
Peter Sandercock
Steff Lewis
P2860
P304
P356
10.1136/BMJ.39456.688333.BE
P407
P577
2008-01-29T00:00:00Z